Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.2 EUR | +1.05% | -1.04% | -24.20% |
04-25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FORMYCON AG | Other Biotechnology & Medical Research | -0.93% | -1.04% | -24.20% | -40.62% | +26.11% | 813M |
- Stock Market
- Equities
- FYB Stock
- Charts Formycon AG
- Relative Strength Chart